Treatment of Mitral Regurgitation Using a Minimally Invasive Approach With the HARPOON Device.
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Mitral Regurgitation
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
This trial is a single arm, prospective, multi-center, non-randomized and open-label post-market study that will evaluate subjects for up to 5 years post treatment.
This trial is a single arm, prospective, multi-center, non-randomized and open-label post-market study that will evaluate subjects for up to 5 years post treatment.
Tracking Information
- NCT #
- NCT04382612
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Thomas Walther, Prof Dr med University Hospital, Frankfurt Principal Investigator: Payam Akhyari, Prof Dr med Heine University Dusseldorf
Get Well Soon